Minogue Sean C, Ralph James, Lampa Martin J
From the Department of Anesthesia, Vancouver General Hospital and the University of British Columbia, Vancouver, BC, Canada.
Anesth Analg. 2004 Oct;99(4):1253-1257. doi: 10.1213/01.ANE.0000132779.27085.52.
Coughing on emergence can result in a number of undesirable side effects, including hypertension, tachycardia, tachyarrhythmias, increased intracranial pressure, and increased intraocular pressure. The efficacy of endotracheal spraying with lidocaine at the time of intubation in preventing coughing on emergence is unknown. In a double-blind placebo-controlled study, we randomized 50 ASA physical status I and II patients presenting for elective gynecological surgery <2 h duration to receive either endotracheal lidocaine 160 mg or placebo before intubation. Both groups were comparable in terms of demographics and intraoperative conditions. The incidence of coughing before tracheal extubation was less frequent in the lidocaine group (26%) than in the placebo group (66%, P < 0.01), as was the incidence after tracheal extubation (4% versus 30%, P = 0.022). This study supports the use of endotracheal lidocaine before intubation in patients undergoing general anesthesia for surgery <2 h duration where coughing on emergence is undesirable.
苏醒期咳嗽可导致多种不良副作用,包括高血压、心动过速、快速性心律失常、颅内压升高和眼压升高。插管时气管内喷洒利多卡因预防苏醒期咳嗽的效果尚不清楚。在一项双盲安慰剂对照研究中,我们将50例拟行择期妇科手术、手术时间<2小时的美国麻醉医师协会(ASA)身体状况I级和II级患者随机分为两组,在插管前分别给予气管内利多卡因160mg或安慰剂。两组在人口统计学和术中情况方面具有可比性。利多卡因组气管拔管前咳嗽发生率(26%)低于安慰剂组(66%,P<0.01),气管拔管后咳嗽发生率也是如此(4%对30%,P=0.022)。本研究支持在手术时间<2小时、苏醒期咳嗽不良的全身麻醉患者插管前使用气管内利多卡因。